CORD-19:c654596857bce9cdd64ffc51842048643107348c / 366717-366976 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3144","span":{"begin":0,"end":259},"obj":"Sentence"},{"id":"T99850","span":{"begin":0,"end":259},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To analyze HBV genotype-related clinical differences among patients with chronic HBV infection, all 158 patients were serially tested for serum alanine aminotransferase (ALT) and hepatitis B e antigen (HBeAg) and followed up for a mean 10.8 (6.4) year period."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T144","span":{"begin":0,"end":259},"obj":"Sentence"}],"text":"To analyze HBV genotype-related clinical differences among patients with chronic HBV infection, all 158 patients were serially tested for serum alanine aminotransferase (ALT) and hepatitis B e antigen (HBeAg) and followed up for a mean 10.8 (6.4) year period."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T775","span":{"begin":179,"end":188},"obj":"Phenotype"}],"attributes":[{"id":"A775","pred":"hp_id","subj":"T775","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"To analyze HBV genotype-related clinical differences among patients with chronic HBV infection, all 158 patients were serially tested for serum alanine aminotransferase (ALT) and hepatitis B e antigen (HBeAg) and followed up for a mean 10.8 (6.4) year period."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T481","span":{"begin":138,"end":143},"obj":"Body_part"}],"attributes":[{"id":"A481","pred":"uberon_id","subj":"T481","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"To analyze HBV genotype-related clinical differences among patients with chronic HBV infection, all 158 patients were serially tested for serum alanine aminotransferase (ALT) and hepatitis B e antigen (HBeAg) and followed up for a mean 10.8 (6.4) year period."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1789","span":{"begin":85,"end":94},"obj":"Disease"},{"id":"T1790","span":{"begin":170,"end":173},"obj":"Disease"},{"id":"T1792","span":{"begin":179,"end":190},"obj":"Disease"},{"id":"T1793","span":{"begin":179,"end":188},"obj":"Disease"},{"id":"T91611","span":{"begin":85,"end":94},"obj":"Disease"},{"id":"T52446","span":{"begin":179,"end":190},"obj":"Disease"},{"id":"T97437","span":{"begin":179,"end":188},"obj":"Disease"}],"attributes":[{"id":"A1789","pred":"mondo_id","subj":"T1789","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A1790","pred":"mondo_id","subj":"T1790","obj":"http://purl.obolibrary.org/obo/MONDO_0005103"},{"id":"A1791","pred":"mondo_id","subj":"T1790","obj":"http://purl.obolibrary.org/obo/MONDO_0006097"},{"id":"A1792","pred":"mondo_id","subj":"T1792","obj":"http://purl.obolibrary.org/obo/MONDO_0005344"},{"id":"A1793","pred":"mondo_id","subj":"T1793","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A9922","pred":"mondo_id","subj":"T91611","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A69968","pred":"mondo_id","subj":"T52446","obj":"http://purl.obolibrary.org/obo/MONDO_0005344"},{"id":"A81198","pred":"mondo_id","subj":"T97437","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"}],"text":"To analyze HBV genotype-related clinical differences among patients with chronic HBV infection, all 158 patients were serially tested for serum alanine aminotransferase (ALT) and hepatitis B e antigen (HBeAg) and followed up for a mean 10.8 (6.4) year period."}